Molecular basis of C-reactive protein binding and modulation of complement activation by factor H-related protein 4

Molecular Immunology

Volumn 47, Issue 6, 2010, Pages 1347-1355

  Hebecker, Mario ^a   Okemefuna, Azubuike I ^b   Perkins, Stephen J ^b   Mihlan, Michael ^a   Huber Lang, Markus ^c   Józsi, Mihály ^a  

^a HANS KNÖLL INSTITUTE   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF ULM MEDICAL SCHOOL   (Germany)

Author keywords

C reactive protein; Complement; Factor H; Factor H related protein 4; Innate immunity; Opsonization; Pentraxin

Indexed keywords

BINDING PROTEIN; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H RELATED PROTEIN 4; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING SITE; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; CONSENSUS SEQUENCE; CONTROLLED STUDY; GENE MUTATION; INSECT CELL; MOLECULAR MODEL; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; AMINO ACIDS; APOLIPOPROTEINS; BINDING SITES; C-REACTIVE PROTEIN; COMPLEMENT ACTIVATION; COMPLEMENT C3; CONSENSUS SEQUENCE; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; PEPTIDE FRAGMENTS; PROTEIN ARRAY ANALYSIS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; REPETITIVE SEQUENCES, AMINO ACID; SEQUENCE ANALYSIS, PROTEIN; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 76949102847     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.12.005     Document Type: Article

References (36)

1. Abarrategui-Garrido C., Martinez-Barricarte R., Lopez-Trascasa M., Rodriguez de Cordoba S., and Sanchez-Corral P. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome. Blood 114 (2009) 4261-4271
2. Berman S., Gewurz H., and Mold C. Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis. J. Immunol. 136 (1986) 1354-1359
3. Bíró A., Rovó Z., Papp D., Cervenak L., Varga L., Füst G., Thielens N.M., Arlaud G.J., and Prohászka Z. Studies on the interactions between C-reactive protein and complement proteins. Immunology 121 (2007) 40-50
4. Black S., Kushner I., and Samols D. C-reactive protein. J. Biol. Chem. 279 (2004) 48487-48490
5. Diehl E.E., Haines III G.K., Radosevich J.A., and Potempa L.A. Immunohistochemical localization of modified C-reactive protein antigen in normal vascular tissue. Am. J. Med. Sci. 319 (2000) 79-83
6. Friberg N., Carlson P., Kentala E., Mattila P.S., Kuusela P., Meri S., and Jarva H. Factor H binding as a complement evasion mechanism for an anaerobic pathogen. Fusobacterium necrophorum. J. Immunol. 181 (2008) 8624-8632
7. Gershov D., Kim S., Brot N., and Elkon K.B. C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J. Exp. Med. 192 (2000) 1353-1364
8. Giannakis E., Jokiranta T.S., Male D.A., Ranganathan S., Ormsby R.J., Fischetti V.A., Mold C., and Gordon D.L. A common site within factor H SCR 7 responsible for binding heparin. C-reactive protein and streptococcal M protein. Eur. J. Immunol. 33 (2003) 962-969
9. Hakobyan S., Harris C.L., van den Berg C.W., Fernandez-Alonso M.C., Goicoechea de Jorge E., Rodriguez de Cordoba S., Rivas G., Mangione P., Pepys M.B., and Morgan B.P. Complement factor H binds to denatured rather than to native pentameric C-reactive protein. J. Biol. Chem. 283 (2008) 30451-30460
10. Hellwage J., Jokiranta T.S., Koistinen V., Vaarala O., Meri S., and Zipfel P.F. Functional properties of complement factor H-related proteins FHR-3 and FHR-4: binding to the C3d region of C3b and differential regulation by heparin. FEBS Lett. 462 (1999) 345-352
11. Hellwage J., Jarva H., Zipfel P.F., and Meri S. Factor H-related proteins interact with C-reactive protein. Immunopharmacology 49 (2000) 70 (abstract)
12. Hellwage J., Jokiranta T.S., Friese M.A., Wolk T.U., Kampen E., Zipfel P.F., and Meri S. Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H. J. Immunol. 169 (2002) 6935-6944
13. Herbert A.P., Deakin J.A., Schmidt C.Q., Blaum B.S., Egan C., Ferreira V.P., Pangburn M.K., Lyon M., Uhrín D., and Barlow P.N. Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism. J. Biol. Chem. 282 (2007) 18960-18968
14. Jarva H., Jokiranta T.S., Hellwage J., Zipfel P.F., and Meri S. Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11. J. Immunol. 163 (1999) 3957-3962
15. Józsi M., Richter H., Löschmann I., Skerka C., Buck F., Beisiegel U., Erdei A., and Zipfel P.F. FHR-4A: a new factor H-related protein is encoded by the human FHR-4 gene. Eur. J. Hum. Genet. 13 (2005) 321-329
16. Józsi M., and Zipfel P.F. Factor H family proteins and human diseases. Trends Immunol. 29 (2008) 380-387
17. Kühn S., and Zipfel P.F. The baculovirus expression vector pBSV-8His directs secretion of histidine-tagged proteins. Gene 162 (1995) 225-229
18. McRae J.L., Duthy T.G., Griggs K.M., Ormsby R.J., Cowan P.J., Cromer B.A., McKinstry W.J., Parker M.W., Murphy B.F., and Gordon D.L. Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein. J. Immunol. 174 (2005) 6250-6256
19. Mevorach D., Mascarenhas J.O., Gershov D., and Elkon K.B. Complement-dependent clearance of apoptotic cells by human macrophages. J. Exp. Med. 188 (1998) 2313-2320
20. Mihlan M., Hebecker M., Dahse H.-M., Hälbich S., Huber-Lang M., Dahse R., Zipfel P.F., and Józsi M. Human complement factor H-related protein 4 binds and recruits native pentameric C-reactive protein to necrotic cells. Mol. Immunol. 46 (2009) 335-344
21. Mihlan M., Stippa S., Józsi M., and Zipfel P.F. Monomeric CRP contributes to complement control in fluid phase and on cellular surfaces and increases phagocytosis by recruiting factor H. Cell Death Differ. 16 (2009) 1630-1640
22. Mold C., Baca R., and Du Clos T.W. Serum amyloid P component and C-reactive protein opsonize apoptotic cells for phagocytosis through Fcgamma receptors. J. Autoimmun. 19 (2002) 147-154
23. Moore I., Strain L., Pappworth I., Kavanagh D., Barlow P.N., Herbert A.P., Schmidt C.Q., Staniforth S.J., Holmes L.V., Ward R., Morgan L., Goodship T.H., and Marchbank K.J. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4 and with mutations in CFH, CFI, CD46, and C3 in patients with atypical haemolytic uraemic syndrome. Blood (2009) 10.1182/blood-2009-05-221549 (Epub ahead of print)
24. Nauta A.J., Daha M.R., van Kooten C., and Roos A. Recognition and clearance of apoptotic cells: a role for complement and pentraxins. Trends Immunol. 24 (2003) 148-154
25. Okemefuna A.I., Nan R., Miller A., Gor J., and Perkins S.J. Complement factor H binds at two independent sites to C-reactive protein in acute-phase concentrations. J. Biol. Chem. 285 (2010) 1053-1065
26. Pepys M.B., and Hirschfield G.M. C-reactive protein: a critical update. J. Clin. Invest. 111 (2003) 1805-1812
27. Prosser B.E., Johnson S., Roversi P., Herbert A.P., Blaum B.S., Tyrrell J., Jowitt T.A., Clark S.J., Tarelli E., Uhrín D., Barlow P.N., Sim R.B., Day A.J., and Lea S.M. Structural basis for complement factor H linked age-related macular degeneration. J. Exp. Med. 204 (2007) 2277-2283
28. Saunders R.E., Abarrategui-Garrido C., Frémeaux-Bacchi V., Goicoechea de Jorge E., Goodship T.H.J., López Trascasa M., Noris M., Ponce Castro I.M., Remuzzi G., Rodríguez de Córdoba S., Sánchez-Corral P., Skerka C., Zipfel P.F., and Perkins S.J. The interactive factor H-atypical haemolytic uraemic syndrome mutation database and website: update and integration of membrane cofactor protein and factor I mutations with structural models. Hum. Mutat. 28 (2007) 222-234
29. Schwedler S.B., Guderian F., Dämmrich J., Potempa L.A., and Wanner C. Tubular staining of modified C-reactive protein in diabetic chronic kidney disease. Nephrol. Dial. Transplant. 18 (2003) 2300-2307
30. Sjöberg A.P., Trouw L.A., McGrath F.D., Hack C.E., and Blom A.M. Regulation of complement activation by C-reactive protein: targeting of the inhibitory activity of C4b-binding protein. J. Immunol. 176 (2006) 7612-7620
31. Sjöberg A.P., Trouw L.A., and Blom A.M. Complement activation and inhibition: a delicate balance. Trends Immunol. 30 (2009) 83-90
32. Skerka C., Hellwage J., Weber W., Tilkorn A., Buck F., Marti T., Kampen E., Beisiegel U., and Zipfel P.F. The human factor H-related protein 4 (FHR-4). A novel short consensus repeat-containing protein is associated with human triglyceride-rich lipoproteins. J. Biol. Chem. 272 (1997) 5627-5634
33. Torzewski J., Torzewski M., Bowyer D.E., Fröhlich M., Koenig W., Waltenberger J., Fitzsimmons C., and Hombach V. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 1386-1392
34. Trouw L.A., Bengtsson A.A., Gelderman K.A., Dahlbäck B., Sturfelt G., and Blom A.M. C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack. J. Biol. Chem. 282 (2007) 28540-28548
35. Volanakis J.E. Human C-reactive protein: expression, structure, and function. Mol Immunol. 38 (2001) 189-197
36. Zipfel P.F., Edey M., Heinen S., Józsi M., Richter H., Misselwitz J., Hoppe B., Routledge D., Strain L., Hughes A.E., Goodship J.A., Licht C., Goodship T.H., and Skerka C. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome. PLoS Genet. 3 (2007) e41